Pharma Foods International Co., Ltd. Logo

Pharma Foods International Co., Ltd.

Researches and sells functional ingredients and direct-to-consumer health & beauty products.

2929 | T

Overview

Corporate Details

ISIN(s):
JP3802310007
LEI:
Country:
Japan
Address:
京都市西京区御陵大原1番地49
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Pharma Foods International Co., Ltd. develops and sells functional food ingredients and related consumer products. The company operates through two main segments: a functional materials business and a direct-to-consumer (B2C) business. The functional materials division researches and develops unique, science-backed ingredients with a focus on areas such as immunity, aging, and the nervous system. The B2C segment utilizes these proprietary ingredients in its e-commerce and wholesale distribution of supplements, cosmetics, and non-pharmaceutical products. Guided by a mission to create food products with pharmaceutical-like efficacy, the company aims to promote health and improve quality of life, and is also engaged in biomedical drug discovery.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-21 08:34
Registration Form
確認書
Japanese 8.2 KB
2025-10-21 08:32
Annual Report
有価証券報告書-第28期(2024/08/01-2025/07/31)
Japanese 1.4 MB
2025-06-05 08:32
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.2 KB
2025-03-14 05:31
Report Publication Announcement
確認書
Japanese 8.2 KB
2025-03-14 05:30
Interim Report
半期報告書-第28期(2024/08/01-2025/07/31)
Japanese 292.0 KB
2024-11-18 07:36
Share Issue/Capital Change
臨時報告書
Japanese 29.9 KB
2024-10-28 07:43
Registration Form
訂正有価証券届出書(参照方式)
Japanese 50.6 KB
2024-10-28 07:35
Post-Annual General Meeting Information
臨時報告書
Japanese 28.6 KB
2024-10-24 08:35
Registration Form
訂正有価証券届出書(参照方式)
Japanese 51.3 KB
2024-10-24 08:33
Registration Form
確認書
Japanese 8.2 KB
2024-10-24 08:32
Governance Information
内部統制報告書-第27期(2023/08/01-2024/07/31)
Japanese 22.7 KB
2024-10-24 08:30
Annual Report
有価証券報告書-第27期(2023/08/01-2024/07/31)
Japanese 1.4 MB
2024-10-22 07:50
Registration Form
有価証券届出書(参照方式)
Japanese 64.0 KB
2024-06-14 06:03
Report Publication Announcement
確認書
Japanese 8.2 KB
2024-06-14 06:02
Quarterly Report
四半期報告書-第27期第3四半期(2024/02/01-2024/04/30)
Japanese 184.3 KB

Automate Your Workflow. Get a real-time feed of all Pharma Foods International Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Pharma Foods International Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Pharma Foods International Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
ArcticZymes Technologies Logo
Develops novel enzymes from Arctic organisms for diagnostics, therapeutics, and biopharma.
Norway AZT
Arcturus Therapeutics Holdings Inc. Logo
Develops mRNA therapeutics and vaccines for rare respiratory, liver, and infectious diseases.
United States of America ARCT
Arcus Biosciences, Inc. Logo
A clinical-stage biopharma developing small molecule and antibody combination therapies for cancer.
United States of America RCUS
Arcutis Biotherapeutics, Inc. Logo
Develops and commercializes non-steroidal therapies for immune-mediated skin diseases.
United States of America ARQT
ARDELYX, INC. Logo
Biopharma developing first-in-class drugs for cardiorenal and GI diseases like IBS-C and CKD.
United States of America ARDX
ARECOR THERAPEUTICS PLC Logo
Biopharma firm enhancing drugs via reformulation for diabetes and pharmaceutical partners.
United Kingdom AREC
argenx SE Logo
Develops first-in-class antibody therapies for severe autoimmune diseases.
Netherlands 1AE
Armata Pharmaceuticals, Inc. Logo
Developing bacteriophage therapeutics for antibiotic-resistant infections.
United States of America ARMP
AroCell AB Logo
Develops and markets diagnostic tests for monitoring cancer and bacterial diseases.
Sweden AROC
ArriVent BioPharma, Inc. Logo
A clinical-stage biopharma developing in-licensed oncology drugs for difficult-to-treat diseases.
United States of America AVBP

Talk to a Data Expert

Have a question? We'll get back to you promptly.